BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31642210)

  • 1. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
    Wu W; Wu M; Peng G; Shi D; Zhang J
    Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.
    Arciero CA; Diehl AH; Liu Y; Sun Q; Gillespie T; Li X; Subhedar P
    J Surg Oncol; 2020 Nov; 122(6):1232-1239. PubMed ID: 32668059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
    Lin S; Liu C; Tao Z; Zhang J; Hu X
    Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
    Meattini I; Pezzulla D; Saieva C; Bernini M; Orzalesi L; Sanchez LJ; Desideri I; Francolini G; Bonomo P; Greto D; Loi M; Mangoni M; Bruni A; Nori J; Vezzosi V; Bianchi S; Livi L
    Clin Breast Cancer; 2018 Oct; 18(5):e773-e780. PubMed ID: 29573977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
    Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
    Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Li H; Chen Y; Wang X; Tang L; Guan X
    Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
    Zhao S; Ma D; Xiao Y; Jiang YZ; Shao ZM
    Eur J Surg Oncol; 2018 Apr; 44(4):420-428. PubMed ID: 29429597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
    Yao Y; Chu Y; Xu B; Hu Q; Song Q
    Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis.
    Mills MN; Yang GQ; Oliver DE; Liveringhouse CL; Ahmed KA; Orman AG; Laronga C; Hoover SJ; Khakpour N; Costa RLB; Diaz R
    Eur J Cancer; 2018 Jul; 98():48-58. PubMed ID: 29870876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
    Kim JY; Park S; Cho EY; Lee JE; Jung HH; Chae BJ; Kim SW; Nam SJ; Cho SY; Park YH; Ahn JS; Lee S; Im YH
    Exp Mol Med; 2023 Jul; 55(7):1451-1461. PubMed ID: 37394589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database.
    Zhang N; Zhang H; Chen T; Yang Q
    Oncotarget; 2017 Apr; 8(15):24579-24592. PubMed ID: 28445946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of the prognostic staging system in the 8th edition of the American Joint Committee on Cancer for triple-negative breast cancer: a SEER population-based analysis.
    Liu YY; Yu TJ; Liu GY
    Future Oncol; 2019 Feb; 15(4):391-400. PubMed ID: 30620221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.